The CIBMTR score predicts of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Midollo Osseo (GITMO).

Todisco E;Ciceri F;Oldani E;Boschini C;Mice C;VanLint M C;Donnini I;Patriarca F;Alessandrino P E;Bonifazi F;Arcese W;Barberi W;Marenco P;Terruzzi E;Cortellazzo S;Santarone S;Proia A;Corradini P;Tagliaferri E;Falcioni S;Irrera G;Dallanegra L;Castagna L;Santoro A;Camboni A;Sacchi N;Bosi A;Bacigalupo A;Rambaldi A

2013-01-01